avatar

We are just two months away from the 16th annual Dialogue for Action conference on cancer screening. The conference offers the opportunity to network with a diverse audience of professionals making great strides in the field of cancer prevention and early detection across the country. Last year’s participants offer compelling reasons why you should register now for the 2014 Dialogue for Action™: Right-Sizing Cancer Screening!

Over 90% of participants shared information from the last year’s Dialogue with colleagues or family members.

Participants were asked what they’ve done in their communities or workplaces as a result of attending the Dialogue conference. Their answers included:

  • Working to deliver clear messages about screening guidelines.
  • Exploring new projects on sun protection and lung cancer.
  • Working on educating clinical teams about quality screening.
  • Using social media more to communicate the message of cancer screening.

“I shared guidelines/benefits/harms around prostate cancer screening with family members,” answered one 2013 Dialogue participant. Another offered, “After the conference evaluation training, I developed an evaluation plan and have used it with the entire staff to begin to document our program.”

“I have recommended the conference to all of our contracted providers in the state,” says Gloria Powell, BSN, RN, a nurse consultant for the Connecticut Department of Public Health.

Join this motivated and energetic group! Attend the 2014 Dialogue, network with a diverse audience and take home practical action steps for cancer prevention and early detection in your community or workplace.

About the Conference
The 2014 Dialogue for Action™: Right-Sizing Cancer Screening will take place on March 20-21, at the Renaissance Baltimore Harborplace Hotel in Baltimore, Maryland, with pre-conference sessions on March 19. The Dialogue covers the mandated guidelines-driven cancer screenings seen in quality measures (colorectal, cervical and breast cancer screenings) and issues related to other cancer screenings (such as oral, prostate and lung).